Taxifolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease via inhibiting inflammation and apoptosis
- 28 December 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 115, 109577
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2018JJ3763)
- National Natural Science Foundation of China (81873410, 81900042, 82070049)
This publication has 26 references indexed in Scilit:
- Inflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2016
- Chronic obstructive pulmonary diseaseNature Reviews Disease Primers, 2015
- Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosisFood and Chemical Toxicology, 2014
- Inflammation in COPD: Implications for ManagementThe American Journal of Medicine, 2012
- Role of apoptosis in the pathogenesis of COPD and pulmonary emphysemaRespiratory Research, 2006
- Time course of cigarette smoke-induced pulmonary inflammation in miceEuropean Respiratory Journal, 2005
- Cigarette Smoke-induced Airway Hyperresponsiveness Is Not Dependent on Elevated Immunoglobulin and Eosinophilic Inflammation in a Mouse Model of Allergic Airway DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladderBritish Journal of Cancer, 1985
- Cigarette Smoke: Effect of Aqueous and Nonaqueous Fractions on Mitochondrial FunctionNature, 1973
- Quantitative Methods in the Study of Pulmonary PathologyThorax, 1962